CYCLE PHARMACEUTICALS LTD

07933058
Active Cambridge

Manufacture of basic pharmaceutical products

54 employees website.com
Life sciences and medical technology Manufacture of basic pharmaceutical products
C

CYCLE PHARMACEUTICALS LTD

07933058

Manufacture of basic pharmaceutical products

Founded 2 Feb 2012 Active Cambridge, England 54 employees website.com
Life sciences and medical technology Manufacture of basic pharmaceutical products
Accounts Submitted 6 Jun 2026 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 27 Jan 2026 Next due 10 Feb 2027 7 months remaining
Net assets £49K £43M 2024 year on year
Total assets £92K £64M 2024 year on year
Total Liabilities £43K £20M 2024 year on year
Charges 5
2 outstanding 3 satisfied

Contact & Details

Contact

Registered Address

The Broers Building 21 Jj Thomson Ave Cambridge CB3 0FA England

Telephone

0800 000 0000

Website

www.example.com

Full company profile for CYCLE PHARMACEUTICALS LTD (07933058), an active life sciences and medical technology company based in Cambridge, England. Incorporated 2 Feb 2012. Manufacture of basic pharmaceutical products. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Balance Sheet & P&L (2014–2024)

Cash in Bank

£54.49k

Decreased by £20.24M (-100%)

Net Assets

£48.63k

Decreased by £43.50M (-100%)

Total Liabilities

£43.02k

Decreased by £20.40M (-100%)

Turnover

£106.61k

Decreased by £85.53M (-100%)

Employees

54

Increased by 12 (+29%)

Debt Ratio

47%

Increased by 15 (+47%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 1

Investors (1)

Investor NameInvestor SinceParticipating Rounds
Investor 1Sept 2020Debt Financing

Share Capital

Share Capital

Share allotments and capital structure

7 Allotments 792,976 Shares £975132.00m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
11 Sept 201832,228£1.52m£47.09
11 Sept 20181,000£18k£17.91
27 Jun 2014233,334£975129.94m£4.18m
18 Apr 2014526,154£526k£1
10 Feb 20146£6£1

Officers

Officers

2 active 1 resigned
Status
James Alexander HarrisonDirectorBritishEngland5221 Dec 2021Active
Sarah Jean GowingDirectorBritishEngland5629 Sept 2021Active

Shareholders

Shareholders (1)

Cycle Group Holdings Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased
Active
Notified 29 Sept 2020
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent

James Alexander Harrison

Ceased 29 Sept 2020

Ceased

Group Structure

Group Structure

CYCLE PHARMACEUTICALS LTD Current Company

Charges

Charges

2 outstanding 3 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
6 Jun 2026AccountsAnnual accounts made up to 31 Dec 2025
6 Jun 2026AccountsAnnual accounts made up to 31 Dec 2025
27 Jan 2026Confirmation StatementConfirmation statement made on 27 Jan 2026 with no updates
13 Nov 2025OfficersTermination of Sarah Jean Gowing as director on 13 Nov 2025
13 Nov 2025OfficersAppointment of Ms Andrea Curti Reiner as director on 13 Nov 2025
6 Jun 2026 Accounts

Annual accounts made up to 31 Dec 2025

6 Jun 2026 Accounts

Annual accounts made up to 31 Dec 2025

27 Jan 2026 Confirmation Statement

Confirmation statement made on 27 Jan 2026 with no updates

13 Nov 2025 Officers

Termination of Sarah Jean Gowing as director on 13 Nov 2025

13 Nov 2025 Officers

Appointment of Ms Andrea Curti Reiner as director on 13 Nov 2025

Recent Activity

Latest Activity

Annual accounts made up to 31 Dec 2025

2 weeks ago on 6 Jun 2026

Annual accounts made up to 31 Dec 2025

2 weeks ago on 6 Jun 2026

Confirmation statement made on 27 Jan 2026 with no updates

4 months ago on 27 Jan 2026

Termination of Sarah Jean Gowing as director on 13 Nov 2025

7 months ago on 13 Nov 2025

Appointment of Ms Andrea Curti Reiner as director on 13 Nov 2025

7 months ago on 13 Nov 2025